US equities
|
TSLA
$391.62
▲+5.21%
MU
$903.70
▲+2.98%
META
$630.56
▼-1.88%
NVDA
$216.00
▲+2.39%
AAPL
$343.91
▼-1.10%
SPCX
$146.90
▼-0.40%
MSFT
$532.60
▲+1.54%
AMD
$531.28
▲+2.80%
TSLA
$391.62
▲+5.21%
MU
$903.70
▲+2.98%
META
$630.56
▼-1.88%
NVDA
$216.00
▲+2.39%
AAPL
$343.91
▼-1.10%
SPCX
$146.90
▼-0.40%
MSFT
$532.60
▲+1.54%
AMD
$531.28
▲+2.80%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Talis Biomedical Corporation - common stock
(NQ:
TLIS
)
4.380
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Talis Biomedical Corporation - common stock
< Previous
1
2
3
Next >
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and RTR on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 27, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
February 15, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 09, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
November 14, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
August 10, 2023
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
August 03, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
August 02, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu
July 27, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 24, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical Announces 1-for-15 Reverse Stock Split
July 05, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 21, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director
May 23, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
May 11, 2023
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023
May 04, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical Corporation (TLIS) Stockholders: Robbins LLP is Investigating TLIS on Behalf of Shareholders
May 02, 2023
From
Robbins LLP
Via
Business Wire
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
March 22, 2023
From
Talis Biomedical Corporation
Via
GlobeNewswire
Talis Biomedical Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Talis Biomedical Corporation
Via
GlobeNewswire
NASDAQ:TLIS Long Term Investor Alert: Investigation of Potential Wrongdoing at Talis Biomedical Corporation
↗
May 10, 2022
San Diego, CA -- (SBWIRE) -- 05/10/2022 -- Certain directors of Talis Biomedical Corporation are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Final Deadline Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
March 08, 2022
Los Angeles - (NewMediaWire) - March 08, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Corporation...
Via
NewMediaWire
Topics
Lawsuit
TLIS FINAL DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Action TLIS
March 08, 2022
WHY: NEW YORK, NY - (NewMediaWire) - March 8, 2022 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Talis Biomedical Corporation (NASDAQ: TLIS) pursuant...
Via
NewMediaWire
Deadline Tomorrow Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
March 07, 2022
Los Angeles - (NewMediaWire) - March 07, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Corporation...
Via
NewMediaWire
Topics
Lawsuit
Talis Biomedical Corporation (NASDAQ:TLIS) Investor Notice: Deadline in Lawsuit on March 8, 2021
↗
March 07, 2022
San Diego, CA -- (SBWIRE) -- 03/07/2022 -- The Shareholders Foundation announced that a deadline is coming up on March 8, 2021 in the lawsuit filed for certain investors of Talis Biomedical Corporation...
Via
SBWire
Deadline Tuesday Notice: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
March 06, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
TLIS FINAL DEADLINE TUESDAY: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLIS
March 04, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Deadline Tuesday Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
March 03, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Tuesday Deadline Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
March 02, 2022
Los Angeles - (NewMediaWire) - March 02, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Corporation...
Via
NewMediaWire
Topics
Lawsuit
7-Day Deadline Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm
March 01, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
TLIS DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses Over $100K to Secure Counsel Before Important March 8 Deadline in Securities Class Action TLIS
February 27, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses Over $100K to Secure Counsel Before Important March 8 Deadline in Securities Class Action TLIS
February 25, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ROSEN, A TOP RANKED LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action TLIS
February 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
< Previous
1
2
3
Next >
